ICAM1 and neoplasm: Conversely, and surprisingly, no significant difference was observed in [111In]In-anti-ICAM-1 uptake in the irradiated tumours compared to mock-treated controls (19.2 ± 1.8 versus 20.7 ± 1.9%ID/g, P > 0.5).